162 related articles for article (PubMed ID: 2511625)
21. p24 antigenaemia, CD4 lymphocyte counts and the development of AIDS.
Phillips AN; Lee CA; Elford J; Webster A; Janossy G; Griffiths PD; Kernoff PB
AIDS; 1991 Oct; 5(10):1217-22. PubMed ID: 1686179
[TBL] [Abstract][Full Text] [Related]
22. Contribution of antibody response to recombinant HIV-1 gene-encoded products nef, rev, tat, and protease in predicting development of AIDS in HIV-1-infected individuals.
Reiss P; de Wolf F; Kuiken CL; de Ronde A; Dekker J; Boucher CA; Debouck C; Lange JM; Goudsmit J
J Acquir Immune Defic Syndr (1988); 1991; 4(2):165-72. PubMed ID: 1898969
[TBL] [Abstract][Full Text] [Related]
23. Clinical signs and laboratory markers in predicting progression to AIDS in HIV-1 infected patients.
Morfeldt-Månson L; Böttiger B; Nilsson B; von Stedingk LV
Scand J Infect Dis; 1991; 23(4):443-9. PubMed ID: 1683492
[TBL] [Abstract][Full Text] [Related]
24. Free and antibody-complexed antigen and antibody profile in apparently healthy HIV seropositive individuals and in AIDS patients.
Portera M; Vitale F; La Licata R; Alesi DR; Lupo G; Bonura F; Romano N; Di Cuonzo G
J Med Virol; 1990 Jan; 30(1):30-5. PubMed ID: 2106004
[TBL] [Abstract][Full Text] [Related]
25. The initial immune response to HIV and immune system activation determine the outcome of HIV disease.
Sheppard HW; Ascher MS; McRae B; Anderson RE; Lang W; Allain JP
J Acquir Immune Defic Syndr (1988); 1991; 4(7):704-12. PubMed ID: 1675678
[TBL] [Abstract][Full Text] [Related]
26. Predictors of disease progression in HIV-infected homosexual men with CD4+ cells < 200 x 10(6)/l but free of AIDS-defining clinical disease.
Keet IP; Krol A; Koot M; Roos MT; de Wolf F; Miedema F; Coutinho RA
AIDS; 1994 Nov; 8(11):1577-83. PubMed ID: 7848594
[TBL] [Abstract][Full Text] [Related]
27. A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia.
Goedert JJ; Kessler CM; Aledort LM; Biggar RJ; Andes WA; White GC; Drummond JE; Vaidya K; Mann DL; Eyster ME
N Engl J Med; 1989 Oct; 321(17):1141-8. PubMed ID: 2477702
[TBL] [Abstract][Full Text] [Related]
28. Evaluation on HIV serology and immune-stimulation on patients in Tanzania.
Hengster P; Schmutzhard E; Fuchs D; Hofbauer J; Wachter H; Dierich MP
Int J STD AIDS; 1991; 2(3):180-4. PubMed ID: 1907499
[TBL] [Abstract][Full Text] [Related]
29. HIV-serology and lymphocyte subsets in relation to therapy and clinical development in haemophiliacs.
Böttiger B; Blombäck M; Berntorp E; Egberg N; Nilsson IM; Schulman S; Stigendal L; Biberfeld G
Eur J Haematol; 1988 Nov; 41(5):459-66. PubMed ID: 2905274
[TBL] [Abstract][Full Text] [Related]
30. Dermatitis of the face, yellow toe nail changes, hairy leukoplakia and oral candidiasis are clinical indicators of progression to AIDS/opportunistic infection in patients with HIV infection.
Morfeldt-Månson L; Julander I; Nilsson B
Scand J Infect Dis; 1989; 21(5):497-505. PubMed ID: 2587953
[TBL] [Abstract][Full Text] [Related]
31. HLA antigen frequencies in HIV-1 seropositive disease-free individuals and patients with AIDS.
Mann DL; Murray C; Yarchoan R; Blattner WA; Goedert JJ
J Acquir Immune Defic Syndr (1988); 1988; 1(1):13-7. PubMed ID: 3216293
[TBL] [Abstract][Full Text] [Related]
32. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.
Fahey JL; Taylor JM; Detels R; Hofmann B; Melmed R; Nishanian P; Giorgi JV
N Engl J Med; 1990 Jan; 322(3):166-72. PubMed ID: 1967191
[TBL] [Abstract][Full Text] [Related]
33. A longitudinal study of the IgG antibody response to HIV-1 p17 gag protein in HIV-1+ patients with haemophilia: titre and avidity.
Chargelegue D; O'Toole CM; Colvin BT
Clin Exp Immunol; 1993 Sep; 93(3):331-6. PubMed ID: 8370162
[TBL] [Abstract][Full Text] [Related]
34. Detection of HIV antigen and specific antibodies to HIV core and envelope proteins in sera of patients with HIV infection.
Cao YZ; Valentine F; Hojvat S; Allain JP; Rubinstein P; Mirabile M; Czelusniak S; Leuther M; Baker L; Friedman-Kien AE
Blood; 1987 Aug; 70(2):575-8. PubMed ID: 2886162
[TBL] [Abstract][Full Text] [Related]
35. Decline of anti-p24 antibody precedes antigenaemia as correlate of prognosis in HIV-1 infection.
Forster SM; Osborne LM; Cheingsong-Popov R; Kenny C; Burnell R; Jeffries DJ; Pinching AJ; Harris JR; Weber JN
AIDS; 1987 Dec; 1(4):235-40. PubMed ID: 3126771
[TBL] [Abstract][Full Text] [Related]
36. Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudine.
Jacobson MA; Bacchetti P; Kolokathis A; Chaisson RE; Szabo S; Polsky B; Valainis GT; Mildvan D; Abrams D; Wilber J
BMJ; 1991 Jan; 302(6768):73-8. PubMed ID: 1671651
[TBL] [Abstract][Full Text] [Related]
37. Immunological and serological markers predictive of progression to AIDS in a cohort of HIV-infected drug users.
Fernández-Cruz E; Desco M; Garcia Montes M; Longo N; Gonzalez B; Zabay JM
AIDS; 1990 Oct; 4(10):987-94. PubMed ID: 1979743
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factors and staging classification of patients with epidemic Kaposi's sarcoma.
Chachoua A; Krigel R; Lafleur F; Ostreicher R; Speer M; Laubenstein L; Wernz J; Rubenstein P; Zang E; Friedman-Kien A
J Clin Oncol; 1989 Jun; 7(6):774-80. PubMed ID: 2565954
[TBL] [Abstract][Full Text] [Related]
39. Eight year prospective study of HIV infection in a cohort of homosexual men--clinical progression, immunological and virological markers.
Lau RK; Hill A; Jenkins P; Caun K; Forster SM; Weber JN; McManus TJ; Harris JR; Jeffries DJ; Pinching AJ
Int J STD AIDS; 1992; 3(4):261-6. PubMed ID: 1504157
[TBL] [Abstract][Full Text] [Related]
40. Changes in survival after acquired immunodeficiency syndrome (AIDS): 1984-1991.
Jacobson LP; Kirby AJ; Polk S; Phair JP; Besley DR; Saah AJ; Kingsley LA; Schrager LK
Am J Epidemiol; 1993 Dec; 138(11):952-64. PubMed ID: 7903022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
